He et al. [44] found that FEZF1-AS1 knockdown in NSCLC reduces the binding ability of EZH2 and LSD1 to the promoter region of E-cadherin, inhibits the transcription of E-cadherin and affects EMT. The gene discussed is EZH2; the disease is non-small cell lung carcinoma.